HIV Gene Expression Enhances T Cell Susceptibility to Hydrogen Peroxide-Induced Apoptosis

AIDS Research and Human Retroviruses

Volumn 9, Issue 11, 1993, Pages 1107-1113

  Sandstrom, Paul A ^a   Roberts, Beverly ^b   Folks, Thomas M ^b   Buttke, Thomas M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CD4 ANTIGEN; GLUTATHIONE; HYDROGEN PEROXIDE; MERCAPTOETHANOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NORTHERN BLOTTING; OXIDATIVE STRESS; SOUTHERN BLOTTING; T LYMPHOCYTE;

ACATALASIA; ANTIOXIDANTS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE EXPRESSION; GENES, VIRAL; HIV; HUMAN; HYDROGEN PEROXIDE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; STRESS; SUPPORT, NON-U.S. GOV'T;

EID: 0027332758     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1993.9.1107     Document Type: Article

References (50)

1. Rosenberg ZF. and Fauci AS.: AIDS: Etiology, Diagnosis, Treatment and Prevention, 3rd ed. DeVita VT Jr, Hellman S, and Rosenberg SA (Eds.), Lippincott, Philadelphia, 1992, pp. 61–76.
2. Gougeon ML., Olivier R., Garcia S., Guetard D., Dragic T., Dauguet C., and Montagnier L.: Mise en evidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectes par le VIH. CR Acad Sei 1991; 312: 529–537.
3. Terai C., Kombluth RS., Pauza CD., Richman DD., and Carson DA.: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991; 87: 1710–1715.
4. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175: 331–340.
5. Meyaard L., Otto SA., Jonker RR., Mijnster MJ., Keet RP., and Miedema F.: Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217–219.
6. Halliwell B. and Cross CE.: Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Arch Intern Med 1991; 151: 29–31.
7. Dröge W., Eck HP., and Mihm S.: HIV-induced cysteine deficiency and T-cell dysfunction—a rationale for treatment with V-acetylcysteine. Immunol Today 1992; 13: 211–214.
8. Baruchel S. and Wainberg MA.: The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992; 52: 111–114.
9. Sonnerborg A., Carlin G., Akerlund B., and Jarstrand C.: Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis 1988; 20: 287–290.
10. Harakeh S., Jariwalla RJ., and Pauling L.: Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Nati Acad Sei USA 1990; 87: 7245–7249.
11. Legrand-Poels S., Vaira D., Pincemail J., van de Vorst A., and Piette J.: Activation ofhuman immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retrovimses 1990; 6: 1389–1397.
12. Roederer M., Staal FJT., Raju PA., Ela SW., Herzenberg LA., and Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Nati Acad Sei USA 1990; 87: 4884–4888.
13. Staal FJT., Roederer M., Herzenberg LA., and Herzenberg LA. Intracellular thiols regulate activation of nuclear factor NF-kB and transcription of human immunodeficiency virus. Proc Nati Acad Sei USA 1990; 87: 9943–9947.
14. Schreck R., Rieber P., and Baeuerle PA.: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991; 10: 2247–2258.
15. Kalebic T., Kinter A., Poli G., Anderson ME., Meister A., and Fauci AS.: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and V-acetylcysteine. Proc Nati Acad Sei USA 1991; 88: 986–990.
16. Schreck R., Meier B., Marmel DN., Dröge W., and Baeuerle PA.: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175: 1181–1194.
17. Lennon SV., Martin SJ., and Cotter TG.: Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991; 24: 203–214.
18. Sandstrom PA. and Buttke TM.: Autocrine production of extracellular catalase prevents apoptosis of the human CEM T cell line in serum-free media. Proc Nati Acad Sei USA 1993; 90: 4708–4712.
19. Yodoi J. and Uchiyama T.: Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 1992; 13: 405–411.
20. Farber CM., Liebes LF., Kanganis DN., and Silber R.: Human B lymphocytes show greater susceptibility to H202 toxicity than T lymphocytes. J Immunol 1984; 132: 2543–2546.
21. Zoschke DC. and Staite ND.: Suppression of human lymphocyte proliferation by activated neutrophils or H202: surviving cells have an altered T helper/T suppressor ratio and an increased resistance to secondary oxidant exposure. Clin Immunol Immunopathol 1987; 42: 160–170.
22. Sagone AL. Jr, Husney R., Guter H., and Clark L.: Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate. J Immunol 1984; 133: 1488–1494.
23. Staite ND., Messner RR., and Zoschke DC.: Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes. J Immunol 1987; 139: 2424–2430.
24. Rush DN., McKenna RM., Walker SM., Bakkestad-Legara P., and Jeffrey JR.: Catalase increases lymphocyte proliferation in mixed lymphocyte culture. Transplant Proc 1988; 20: 1271–1273.
25. Masutani H., Naito M., Takahashi K., Hattori T., Koito A., Takatsuki K., Go T., Nakamura H., Fujii S., Yoshida Y., Okuma M., and Yodoi J.: Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Res Hum Retrovimses 1992; 9: 1707–1715.
26. Folks TM., Benn S., Rabson A., Theodore T., Hoggan MD., Martin M., Lightfoote M., and Sell K.: Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Nati Acad Sei USA 1985; 82: 4539–4543.
27. Folks TM., Powell D., Lightfoote M., Koenig S., Fauci AS., Benn S., Rabson A., Daugherty D., Gendelman HE., Hoggan MD., Venkatesan S., and Martin MA.: Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986; 164: 280–290.
28. Buttke TM., McCubrey JA., and Owen TC.: Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods 1993; 157: 233–240.
29. Claibome A.: Handbook of Methodsfor Oxygen Radical Research. Greenwald RA (Ed.), CRC Press, Boca Raton, FL, 1985, pp. 283–284.
30. Chesebro B. and Wehrly K.: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988; 62: 3779–3788.
31. Pincus S., Wehrly K., and Chesebro B.: Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates. J Immunol 1989; 142: 3070–3075.
32. Tebbey PW. and Buttke TM.: Arachidonic acid regulates unsaturated fatty acid synthesis in lymphocytes by inhibiting stearoyl-CoA desaturase gene expression. Biochim Biophys Acta 1992; 1171: 27–34.
33. Chang PS., Cantin EM., Zaia JA., Ladne PA., Stephens DA., Sarver N., and Rossi JJ.: Ribozyme-mediated site-specific cleavage of the HIV-1 genome. Clin Biotech 1990; 2: 23–31.
34. +8+ thymocytes by flow cytometry. J Immunol Methods 1991; 137: 79–87.
35. Telford WG., King LE., and Fraker PJ.: Evaluation of glucocorticoidinduced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991; 24: 447–459.
36. Wong GHW., McHugh T., Weber R., and Goeddel DV.: Tumor necrosis factor a selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc Nati Acad Sei USA 1991; 88: 4372–4376.
37. Amstad P., Peskin A., Shah G., Mirault ME., Moret R., Zbinden I., and Cerutti P.: The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 1991; 30: 9306–9313.
38. Fidelus RK.: The generation of oxygen radicals: a positive signal for lymphocyte activation. Cell Immunol 1988; 113: 175–182.
39. Staal FJT., Ela SW., Roederer M., Anderson MT., Herzenberg LA., and Herzenberg LA.: Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992; 339: 909–912.
40. Israel N., Gougerot-Pocidalo MA., Aillet F., and Virelizier JL.: Redox status of cells influences constitutive or induced NF-kB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992; 149: 3386–3393.
41. Larrick JW. and Wright SC.: Cytotoxic mechanism of tumor necrosis factor-a. FASEB J 1990; 4: 3215–3223.
42. Kobayashi N., Hamamoto Y., Yamamoto N., Ishii A., Yonehara M., and Yonehara S.: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Nati Acad Sei USA 1990; 87: 9620–9624.
43. Folks TM., Clouse KA., Justement J., Rabson A., Duh E., Kehrl JH., and Fauci AS.: Tumor necrosis factor a. induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Nati Acad Sei USA 1989; 86: 2365–2368.
44. Lahdevirta J., Maury CPJ., Teppo AM., and Repo H.: Elevated level of circulating cachectin, tumor necrosis alpha in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289–291.
45. Pantaleo G., Graziosi C., Butini L., Pizzo PA., Schnittman SM., Kotler DP., and Fauci AS.: Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Nati Acad Sei USA 1991; 88: 9838–9842.
46. Pantaleo G., Graziosi C., Demarest JF., Butini L., Montroni M., Fox CH., Orenstein JM., Kotler DP., and Fauci AS.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993; 362: 355–358.
47. Embretson J., Zupancic M., Ribas JL., Burke A., Racz P., Tenner-Racz K., and Haase AT.: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993; 362: 359–362.
48. Buhl R., Jaffe HA., Holroyd KJ., Borok Z., Roum JH., Mastrangeli A., Wells FB., Kirby M., Saltini C., and Crystal RG.: Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993; 150: 1019–1028.
49. Arrick BA., Nathan CF., Griffith OW., and Conn ZA.: Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J Biol Chem 1982; 257: 1231–1237.
50. Harlan JM., Levine JD., Callahan KS., and Schwartz BR.: Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest 1984; 73: 706–713.